EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Smart Biosensing Nanomaterials for Alzheimer’s Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood–Brain Barrier

Manickam Rajkumar iD, Furong Tian iD, Bilal Javed iD, Bhupendra G Prajapati iD, Paramasivam Deepak iD, Koyeli Girigoswami iD, Natchimuthu Karmegam iD

Biosensors · 21.01.2026 · 16 (1) · 66

DOI: 10.3390/bios16010066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 21.01.2026. Verfasst von Manickam Rajkumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore 641021, Tamil Nadu, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Blood-Brain Barrier, Drug Delivery Systems, Biosensing Techniques. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by persistent memory impairment and complex molecular and cellular pathological changes in the brain. Current treatments, including acetylcholinesterase inhibitors and memantine, only help with symptoms for a short time and do not stop the disease from getting worse. This is mainly because these drugs do not reach the brain well and are quickly removed from the body. The blood–brain barrier (BBB) restricts the entry of most drugs into the central nervous system; therefore, new methods of drug delivery are needed. Nanotechnology-based drug delivery systems (NTDDS) are widely studied as a potential approach to address existing therapeutic limitations. Smart biosensing nanoparticles composed of polymers, lipids, and metals can be engineered to enhance drug stability, improve drug availability, and target specific brain regions. These smart nanoparticles can cross the BBB via receptor-mediated transcytosis and other transport routes, making them a promising option for treating AD. Additionally, multifunctional nanocarriers enable controlled drug release and offer theranostic capabilities, supporting real-time tracking of AD treatment responses to facilitate more precise and personalized interventions. Despite these advantages, challenges related to long-term safety, manufacturing scalability, and regulatory approval remain. This review discusses current AD therapies, drug-delivery strategies, recent advances in nanoparticle platforms, and prospects for translating nanomedicine into effective, disease-modifying treatments for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBlood-Brain BarrierDrug Delivery SystemsBiosensing TechniquesNanostructuresHumansNanoparticlesAnimals

Stichwörter der Autor:innen

Alzheimer’s diseaseblood–brain barrierdrug delivery systemnanomaterials

Autor:innen und Institutionen

  • Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore 641021, Tamil Nadu, India.
  • Center for Cancer Research, Karpagam Academy of Higher Education, Coimbatore 641021, Tamil Nadu, India.
  • School of Food Science and Environmental Health, Technological University Dublin, Grangegorman, D07 ADY7 Dublin, Ireland.
  • Nanolab Research Centre, Physical to Life Sciences Research Hub, Technological University Dublin, Camden Row, D08 CKP1 Dublin, Ireland.
  • Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara 391760, Gujarat, India.
  • Department of Life Sciences, School of Biological and Forensic Sciences, Kristu Jayanti University, Bengaluru 560077, Karnataka, India.

ORCID-Profile: Manickam Rajkumar, Furong Tian, Bilal Javed, Bhupendra G Prajapati, Paramasivam Deepak, Koyeli Girigoswami, Natchimuthu Karmegam

Zitieren

APA

Rajkumar, M., Tian, F., Javed, B., Prajapati, B. G., Deepak, P., Girigoswami, K., & Karmegam, N. (2026). Smart Biosensing Nanomaterials for Alzheimer’s Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood–Brain Barrier. Biosensors, 16(1), 66. https://doi.org/10.3390/bios16010066

Vancouver

Rajkumar M, Tian F, Javed B, Prajapati BG, Deepak P, Girigoswami K, et al. Smart Biosensing Nanomaterials for Alzheimer’s Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood–Brain Barrier. Biosensors. 2026;16(1):66. doi:10.3390/bios16010066

BibTeX
@article{Rajkumar2026,
  author = {Rajkumar, Manickam and Tian, Furong and Javed, Bilal and Prajapati, Bhupendra G and Deepak, Paramasivam and Girigoswami, Koyeli and Karmegam, Natchimuthu},
  title = {Smart Biosensing Nanomaterials for Alzheimer’s Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood–Brain Barrier},
  journal = {Biosensors},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {66},
  doi = {10.3390/bios16010066}
}
Kostenlos starten →